Recommendations to the Japanese and Australian Governments for future research and development of melanoma neutron capture therapy

No Thumbnail Available
Date
1989
Journal Title
Journal ISSN
Volume Title
Publisher
Alan R. Liss, Inc
Abstract
The paper outlines recommendations for the Japanese and Australian governments to advance research and development in Neutron Capture Therapy (NCT) for malignant melanoma. It highlights successful initial clinical trials utilizing boron compounds, especially 'OB-boronophenylalanine (OB-BPA), and suggests expanding collaborative experiments, enhancing clinical trials, refining therapeutic protocols, and exploring innovative compounds. The potential for improved treatment efficacy with minimal side effects positions NCT as a promising avenue in melanoma therapy. © Alan R. Liss Inc.
Description
Physical copy held by ANSTO Library at DDC: 616.99477/3 Also held as part of a journal Pigment Cell Research Vol. 2, No. 4 (1989) at the same DDC number.
Keywords
Recommendations, Japan, Australia, Research programs, Melanomas, Neutron capture therapy, Gamma dosimetry, Boron compounds, Tumor cells, Radiotherapy, Therapy, Neoplasms, Immunology, Meetings
Citation
Mishima, Y., & Allen, B. J. (1989). Recommendations to the Japanese and Australian Governments for Future Research and Development of Melanoma Neutron Capture Therapy. Paper prsented to the 2nd Japan-Australia International Workshop on Thermal Neutron Capture Therapy for Malignant Melanoma, Kobe, September 23-26, 1987. In Mishima, Y. (ed.). Melanoma neutron capture therapy : proceedings of 2nd Japan-Australia International Workshop on Thermal Neutron Capture Therapy for Malignant Melanoma, Kobe, September 23-26, 1987, (pp. 379-384). New York : Alan R. Liss.